Low dosage promethazine and loratadine negatively affect neuromotor function

Clinical Neurophysiology

Volumn 123, Issue 4, 2012, Pages 780-786

  Kavanagh, Justin J ^a,b   Grant, Gary D ^a,b   Anoopkumar Dukie, Shailendra ^a,b  

^a GRIFFITH UNIVERSITY   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

Antihistamine; Autonomic cardiac regulation; Postural tremor; Reaction time

Indexed keywords

LORATADINE; PROMETHAZINE;

ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFECT; FEMALE; HEART RATE VARIABILITY; HUMAN; HUMAN EXPERIMENT; INVOLUNTARY MOVEMENT; LOW DRUG DOSE; MALE; MOTONEURON; NORMAL HUMAN; PRIORITY JOURNAL; REACTION TIME; SELF REPORT; SINGLE DRUG DOSE; TREMOR; VOLUNTARY MOVEMENT;

CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HISTAMINE H1 ANTAGONISTS; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; LORATADINE; MALE; MOTOR NEURONS; MOVEMENT; PROMETHAZINE; REACTION TIME; SLEEP STAGES; TREMOR; YOUNG ADULT;

EID: 84857790186     PISSN: 13882457     EISSN: 18728952     Source Type: Journal    
DOI: 10.1016/j.clinph.2011.07.046     Document Type: Article

References (30)

1. Betz A.J., McLaughlin P.J., Burgos M., Weber S.M., Salamone J.D. The muscarinic receptor antagonist tropicamide suppresses tremulous jaw movements in a rodent model of parkinsonian tremor: possible role of M4 receptors. Psychopharmacol 2007, 194(3):347-359.
2. Brown T.E., Eckberg D.L. Promethazine affects autonomic cardiovascular mechanisms minimally. J Pharmacol Exp Ther 1997, 282(2):839-844.
3. Bymaster F.P., McKinzie D.L., Felder C.C., Wess J. Use of M1-M5 muscarinic receptor knockout mice as novel tools to delineate the physiological roles of the muscarinic cholinergic system. Neurochem Res 2003, 28(3/4):437-442.
4. Camus M., Ragert P., Vandermeeren Y., Cohen L.G. Mechanisms controlling motor output to a transfer hand after learning a sequential pinch force skill with the opposite hand. Clin Neurophysiol 2009, 120(10):1859-1865.
5. Cerone G., Ruggieri S., Agnoli A. Parkinsonian tremor; a neuropharmacological study. Acta Neurol Belg 1977, 77(4):213-229.
6. Chow J.Y., Davids K., Button C., Koh M. Coordination changes in a discrete multi-articular action as a function of practice. Acta Psychol 2008, 127(1):163-176.
7. Elble R.J., Deuschl G. Milestones in tremor research. Mov Disord 2011, 26(6):1096-1105.
8. Gillard M., Christophe B., Wels B., Peck M., Massingham R., Chatelain P. H1 antagonists: receptor affinity versus selectivity. Inflamm Res 2003, 52(Suppl 1):S49-50.
9. Goodman L.S., Gilman A.G. Goodman Gilman's the pharmacological basis of therapeutics. 2006, McGraw-Hill Publishing Co. inc., New York.
10. Hindmarch I., Johnson S., Meadows R., Kirkpatrick T., Shamsi Z. The acute and sub-chronic effects of Levocetirizine, Cetirizine, Loratadine, Promethazine and Placebo on cognitive function, psychomotor performance, and weal and flare. Curr Med Res Opin 2001, 17(4):241-255.
11. Hindmarch I., Shamsi Z., Stanley N., Fairweather D.B. A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function. Br J Clin Pharmacol 1999, 48(2):200-206.
12. Howell G., West L., Jenkins C., Lineberry B., Yokum D., Rockhold R. In vivo antimuscarinic actions of the third generation antihistaminergic agent, desloratadine. BMC Pharmacol 2005, 5:13.
13. Jáuregui I., Mullol J., Bartra J., del Cuvillo A., Dávila I., Montoro J., et al. H1 antihistamines: psychomotor performance and driving. J Investig Allergol Clin Immunol 2006, 16(Suppl 1):37-44.
14. Jeon J., Dencker D., Wortwein G., Woldbye D.P., Cui Y., Davis A.A., et al. A subpopulation of neuronal M4 muscarinic acetylcholine receptors plays a critical role in modulating dopamine-dependent behaviors. J Neurosci 2010, 30(6):2396-2405.
15. Kanekar N., Santos M.J., Aruin A.S. Anticipatory postural control following fatigue of postural and focal muscles. Clin Neurophysiol 2008, 119(10):2304-2313.
16. Karatas G.K., Günendi Z. Do anticholinergics affect reaction time? A possible impact on the course of rehabilitation. NeuroRehabilitation 2010, 27(2):141-145.
17. Kubo N., Senda M., Ohsumi Y., Sakamoto S., Matsumoto K., Tashiro M., et al. Brain histamine H1 receptor occupancy of loratadine measured by positron emission topography: comparison of H1 receptor occupancy and proportional impairment ratio. Hum Psychopharmacol 2011, 26(2):133-139.
18. Marrocco R.T., Davidson M.C. The neurochemistry of attention. The Attentive Brain 1998, 35-50. MIT Press, Cambridge, MA. R. Parasuraman (Ed.).
19. Mayorga A.J., Cousins M.S., Trevitt J.T., Conlan A., Gianutsos G., Salamone J.D. Characterization of the muscarinic receptor subtype mediating pilocarpine-induced tremulous jaw movements in rats. Eur J Pharmacol 1999, 364(1):7-11.
20. McAuley J.H., Marsden C.D. Physiological and pathological tremors and rhythmic central motor control. Brain 2000, 123(8):1545-1567.
21. Nault M.A., Milne B., Parlow J.L. Effects of the selective H1 and H2 histamine receptor antagonists loratadine and ranitidine on autonomic control of the heart. Anesthesiology 2002, 96(2):336-341.
22. Owczuk R., Twardowski P., Dylczyk-Sommer A., Wujtewicz M.A., Sawicka W., Drogosxewska B., et al. Influence of promethazine on cardiac repolarisation: a doubke-blind, midazolam-controlled study. Anaesthesia 2009, 64:609-614.
23. Pasquet B., Carpentier B., Duchateau J. Change in muscle fascicle length influences the recruitment and discharge rate of motor units during isometric contractions. J Neurophysiol 2005, 94:3126-3133.
24. Ramanathan R., Reyderman L., Kulmatycki K., Su A.D., Alvarez N., Chowdhury S.K., et al. Disposition of loratadine in healthy volunteers. Xenobiotica 2007, 37(7):753-769.
25. Shemmell J., Tresilian J.R., Riek S., Barry B.K., Carson R.G. Neuromuscular adaptation during skill acquisition on a two degree-of-freedom target-acquisition task: dynamic movement. J Neurophysiol 2005, 94(5):3058-3068.
26. Simons F.E. Advances in H1-antihistamines. N Engl J Med 2004, 351(21):2203-2217.
27. Thakkar M.M. Histamine in the regulation of wakefulness. Sleep Med Rev 2011, 15(1):65-74.
28. Wang Y, Zatsiorsky VM, Latash ML. Muscle synergies involved in preparation to a step made under the self-paced and reaction time instructions. Clin Neurophysiol 2006;117(1):41-56.
29. Warburton D., Rusted J. Cholinergic control of cognitive resources. Neuropsychobiol 1993, 28:43-46.
30. Zhang D., Tashiro M., Shibuya K., Okamura N., Funaki Y., Yoshikawa T., et al. Next-day residual sedative effect after nighttime administration of an over-the-counter antihistamine sleep aid, diphenhydramine, measured by positron emission tomography. J Clin Psychopharmacol 2010, 30(6):694-701.